Investment News and Research RSS Feed - Investment News and Research

New lab at the Nencki Institute conducts research on neurodegenerative diseases

New lab at the Nencki Institute conducts research on neurodegenerative diseases

The Laboratory of Preclinical Studies of Higher Standard, the newest lab of the Neurobiology Center at the Nencki Institute in Warsaw, Poland, will conduct basic research aimed to explain molecular mechanisms responsible for neurodegenerative diseases. [More]
Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

​Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history. [More]

Algatechnologies launches AstaPure 20% astaxanthin oleoresin

Algatechnologies Ltd., a leading manufacturer and supplier of natural algae astaxanthin announces the launch of AstaPure 20% astaxanthin oleoresin. This content of astaxanthin exceeds any available in the marketplace. [More]
New analysis finds less research attention is given to diseases of developing world

New analysis finds less research attention is given to diseases of developing world

Death is not distributed equally around the world. In high-income countries, people typically die in old age of chronic diseases such as cancer or cardiovascular problems. In low-income countries, death comes primarily from infectious and perinatal diseases, and strikes at a young age. [More]
Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI, and other institutions have discovered that the activating hotspot L205R mutation in PRKACA gene was closely associated with adrenocortical tumors (ACTs), and the relationship of recurrently mutated DOT1L and CLASP2 with ACTs' other subtypes. [More]

Autocam sponsors 2014 Governor's Education Summit

Autocam Corp is a leading precision manufacturer for both the automotive and medical industries and recently announced it is sponsoring Governor Rick Snyder's Governor's Education Summit taking place on April 24, 2014. Autocam is committed to investment in education, jobs creation and advanced manufacturing technologies. [More]

Bio-Techne makes $10M equity investment in CyVek

Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met. [More]

Concord Medical to establish cancer hospital in Shanghai New Hongqiao International Medical Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the Company will establish Shanghai Concord Cancer Hospital ("Shanghai Concord") - a premium cancer hospital - in Shanghai New Hongqiao International Medical Center. [More]
Research reports on mass spectrometer, Raman spectroscopy and handheld Raman spectroscopy sectors

Research reports on mass spectrometer, Raman spectroscopy and handheld Raman spectroscopy sectors

ReportsnReports.com offers 2014 market research reports on global mass spectrometer industry, global raman spectroscopy industry and global handheld raman spectroscopy sectors. [More]

Accele Venture Partners co-led $4.1M Series A private equity financing of Otologic Pharmaceutics

Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc., announced today that it has co-led a $4.1 million Series A private equity financing of Otologic Pharmaceutics, Inc. (OPI), a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders. [More]
Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round to further advance development of EB-1020 SR, a non-stimulant, for the treatment of all subtypes of adult ADHD (attention deficit hyperactivity disorder). [More]

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round. [More]
Biomet's consolidated net sales increase 6.6% to $822.5 million

Biomet's consolidated net sales increase 6.6% to $822.5 million

Biomet, Inc. announced today financial results for its third quarter ended February 28, 2014. [More]
Study: Good diet means healthy population with lower health costs

Study: Good diet means healthy population with lower health costs

The idea that a good diet means a healthy population with lower health costs only holds true when it comes to emergency care, a study shows. [More]

FDA allows CryoLife to begin PerClot clinical trial in the U.S.

CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration. [More]

GE Healthcare agrees to acquire CHCA Computer Systems

GE Healthcare announced today it has agreed to acquire CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures. [More]

Despite years of investment, female genital cutting still has major support in Somalia, Ethiopia

Despite years of heavy investment, female genital cutting still has major support in countries such as Somalia and Ethiopia. Well intentioned campaigns initiated by international organisations are being met with skepticism. "Changes must come from within," say researchers. [More]

New analysis of the functional beverage market in Australia and New Zealand

Functional beverage manufacturers are acknowledging consumer demand for natural and organic beverages by investing in product innovation, new flavours, and the introduction of balanced nutrients and environment-friendly packages. [More]

Catasys' fourth quarter 2013 revenues up 161%

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today announced financial results for the fourth quarter ended December 31, 2013. [More]

Brewers Community Foundation, Northwestern Mutual partner for ‘Stolen Bases, Happy Faces’ campaign

One in 330 children will be diagnosed with some form of cancer by the time they are 20-years-old. Because treatment plans differ for each of the many forms of the disease, families often have to travel to seek the best care for their child. [More]